Sign in

NCT07692217Recruiting

TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies

Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies (TG-INSIGHT With Joint POCUS)

Source: ClinicalTrials.gov · Last updated 29 Sept 2026

Brief summary (registry, in English)

This is an observational research study to find out if there is a difference in the way children with moderate or severe hemophilia A, treated on two different types of factor replacement, form a clot and also evaluate if they develop tiny bleeds within the joint and subsequently early joint changes when receiving extended half-life factor VIII.

Status (registry)
Recruiting
Study type
Observational
Enrollment
60 (estimated)
First submitted
26 May 2026
Start date
22 Jul 2026
Primary completion date
May 2033
Lead sponsor
University of Texas Southwestern Medical Center
Diseases
Haemophilia
NCT number
NCT07692217

What you commit to

  • Study type: Observational
  • Planned participants: 60
  • From 22 Jul 2026 to the primary completion date, May 2033
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participants with active FVIII inhibitor (\>0.5 BU/mL)

Other illness

  • Presence of an additional bleeding disorder other than hemophilia A

Who the study is looking for

  • Participants with moderate or severe HA who are on prophylaxis with either weekly, biweekly, or every 4-weeks emicizumab or weekly efanesoctocog alfa for at least 2 months.
  • \>6 months of age

Age in the registry: 6 months to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
The University of Texas Southwestern Medical Center
Coordinator of this site? Confirm its status
DallasUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.